Common Contracts
5 similar Securities Purchase Agreement contracts by Pure Bioscience, Inc.
Securities PURCHASE AGREEMENTSecurities Purchase Agreement • October 3rd, 2019 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of October 2, 2019, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Securities PURCHASE AGREEMENTSecurities Purchase Agreement • July 19th, 2019 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of June 21, 2019, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Securities PURCHASE AGREEMENTSecurities Purchase Agreement • June 25th, 2019 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of June 21, 2019, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Securities PURCHASE AGREEMENTSecurities Purchase Agreement • May 13th, 2019 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of June 9, 2019, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Securities PURCHASE AGREEMENTSecurities Purchase Agreement • August 17th, 2018 • Pure Bioscience, Inc. • Miscellaneous chemical products • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of August 16, 2018, among Pure Bioscience, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
